Skip to main content

Table 1 Clinicopathological characteristics of patients with localized PG-DLBCL

From: Localized primary gastrointestinal diffuse large B cell lymphoma received a surgical approach: an analysis of prognostic factors and comparison of staging systems in 101 patients from a single institution

Characteristics

N (%)

5-year RFS

P value

5-year OS

P value

Age (years)

<=60

64 (63)

90.2 ± 4.2 %

0.040

91.8 ± 3.9 %

0.037

>60

37 (37)

69.2 ± 9.3 %

67.0 ± 9.8 %

Sex

Male

57 (56)

89.1 ± 4.6 %

0.244

90.7 ± 4.4 %

0.234

Female

44 (44)

75.4 ± 7.6 %

74.1 ± 8.0 %

B symptoms

No

57 (56)

79.1 ± 6.2

0.190

79.7 ± 6.5 %

0.193

Yes

44 (44)

88.2 ± 5.6 %

87.6 ± 5.8 %

Extranodal involvement

Single site

85 (84)

87.2 ± 4.3 %

0.040

87.8 ± 4.4 %

0.018

Multiple sites

16 (16)

66.0 ± 12.4 %

63.6 ± 13.2 %

LDH

Normal

77 (76)

89.0 ± 4.3 %

0.011

90.9 ± 4.0 %

0.009

Abnormal

24 (24)

63.9 ± 11.0 %

63.6 ± 11.1 %

β2-MG

Normal

50 (50)

94.1 ± 4.1 %

0.034

93.2 ± 4.7 %

0.025

Abnormal

51 (50)

74.4 ± 6.7 %

75.9 ± 6.7 %

Hypoalbuminemia

No

76 (75)

87.5 ± 4.4 %

0.036

88.3 ± 4.6 %

0.025

Yes

25 (25)

70.3 ± 10.3 %

67.9 ± 11.0 %

Anemia

No

56 (55)

89.3 ± 4.5 %

0.144

91.1 ± 4.3 %

0.129

Yes

45 (45)

73.8 ± 8.1 %

71.8 ± 8.6 %

Site of origin

Gastric

48 (47)

90.6 ± 5.2 %

0.012

92.8 ± 5.0 %

0.008

Duodenum and small bowel

17 (17)

74.0 ± 13.2 %

70.7 ± 14.3 %

Ileocecal

16 (16)

86.7 ± 8.8 %

86.7 ± 8.8 %

Colorectal

15 (15)

84.0 ± 10.6 %

82.1 ± 11.7 %

Combined

5 (5)

40.0 ± 21.9 %

40.0 ± 21.9 %

  1. Abbreviations: PG-DLBCL primary gastrointestinal diffuse large B cell lymphoma, RFS relapse-free survival, OS overall survival, LDH lactate dehydrogenase, β2-MG β2-microglobulin